S. G. H. A. Swinnen

A 24-Week, Randomized, Treat-to-Target Trial Comparing Initiation of Insulin Glargine Once-Daily With Insulin Detemir Twice-Daily in Patients With Type 2 Diabetes Inadequately Controlled on Oral Glucose-Lowering Drugs

S. G. H. A. Swinnen, Marie‐Paule Dain, Ronnie Aronson et al. · Diabetes Care · 2010 · 158 citations · Full text

The interpretation of glucose clamp studies of long-acting insulin analogues: from physiology to marketing and back

S. G. H. A. Swinnen, F. Holleman, J. Hans DeVries · Diabetologia · 2008 · 54 citations · Full text

Insulin Signaling, Obesity, Metabolic Syndrome +20

Changing the glucose cut-off values that define hypoglycaemia has a major effect on reported frequencies of hypoglycaemia

S. G. H. A. Swinnen, Peter R. Mullins, Maria Elisa Peinado Miller et al. · Diabetologia · 2008 · 52 citations · Full text

Continuation versus discontinuation of insulin secretagogues when initiating insulin in type 2 diabetes

S. G. H. A. Swinnen, Marie‐Paule Dain, Dı́dac Mauricio et al. · Diabetes Obesity and Metabolism · 2010 · 31 citations

Insulin Resistance, Metabolic Syndrome, Diabetes Management +15

Contact frequency determines outcome of basal insulin initiation trials in type 2 diabetes

S. G. H. A. Swinnen, J. Hans DeVries · Diabetologia · 2009 · 21 citations · Full text